Intellia Therapeutics (NTLA) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156.00 |
| Dec 31, 2025 | 195.00 |
| Sep 30, 2025 | 195.00 |
| Jun 30, 2025 | -501.00 |
| Mar 31, 2025 | -557.00 |
| Dec 31, 2024 | 7.00 |
| Sep 30, 2024 | -317.00 |
| Jun 30, 2024 | -302.00 |
| Mar 31, 2024 | 78.00 |
| Dec 31, 2023 | -379.00 |
| Sep 30, 2023 | -456.00 |
| Jun 30, 2023 | -501.00 |
| Mar 31, 2023 | 778.00 |
| Dec 31, 2022 | 537.00 |
| Sep 30, 2022 | -610.00 |
| Jun 30, 2022 | -566.00 |
| Mar 31, 2022 | -1,005.00 |
| Dec 31, 2021 | 284.00 |
| Sep 30, 2021 | 459.00 |
| Jun 30, 2021 | -638.00 |
| Mar 31, 2021 | 356.00 |
| Dec 31, 2020 | 245.00 |
| Sep 30, 2020 | 567.00 |
| Jun 30, 2020 | 471.00 |
| Mar 31, 2020 | -508.00 |
| Dec 31, 2019 | -370.00 |
| Sep 30, 2019 | -19.00 |
| Jun 30, 2019 | -92.00 |
| Mar 31, 2019 | 85.00 |
| Dec 31, 2018 | 20.00 |
| Sep 30, 2018 | -444.00 |
| Jun 30, 2018 | -360.00 |
| Mar 31, 2018 | 163.00 |
| Dec 31, 2017 | -66.00 |
| Sep 30, 2017 | -474.00 |
| Jun 30, 2017 | -478.00 |
| Mar 31, 2017 | -261.00 |
| Dec 31, 2016 | -247.00 |
| Sep 30, 2016 | 362.00 |
| Jun 30, 2016 | 1,477.00 |